MyChesCo on MSN2mon
Aprea Therapeutics Welcomes Dr. Philippe Pultar as Senior Medical AdvisorDr. Pultar brings a wealth of oncology experience, notably in advancing WEE1 inhibitors, having previously guided azenosertib ...
Zentalis focuses on developing small molecule therapeutics for cancer, with azenosertib being a potentially first-in-class WEE1 inhibitor undergoing clinical trials showing promise against various ...
"We are ahead of schedule with the enrollment of the Phase 1 ACESOT-1051 trial evaluating our next generation WEE1 inhibitor, APR-1051. Preliminary results at subtherapeutic doses demonstrate the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results